We have been transforming lives in healthcare since 1885. Our 53,000 employees in 130 markets create value through innovation by infusing long-term, sustainable thinking into our Human Pharma and Animal Health units.
We acknowledge the deep and complex ways the lives of humans and animals are interconnected and work on breakthrough therapies and co-create solutions that help millions of people worldwide live longer, healthier lives.
Boehringer Ingelheim (BI) is one of the world’s leading research-driven pharmaceutical companies with 130 years of experience. Our focus globally is on improving health and quality of lives of our patients. With 8 leading research based innovative products, BI is one of the leading multinational pharmaceuticals organizations in India. Presently, BI India operates through its business areas of Human Pharma, Animal Health and Clinical operations.
At Boehringer Ingelheim we create value through innovation with one clear goal: to improve the lives of patients. We develop breakthrough therapies and innovative healthcare solutions in areas of unmet medical need for both humans and animals. As a family owned company we focus on long term performance. We are powered by 50.000 employees globally who nurture a diverse, collaborative and inclusive culture.
Envista盈纬达，全球大型口腔设备及耗材研发与制造企业之一，是拥有30多个卓越口腔品牌的大家庭，已有超过130年的历史，因为共同的目标而齐心聚力，那就是携手专业人士，改善生活品质。
我们通过持续创新的产品、技术与解决方案，为全球100多万专业人士提供包括种植牙、口腔正畸与数字成像技术等专业产品与服务，满足口腔医生在诊断、治疗和预防口腔疾病以及微笑美学方面约90%以上的需求，不断创造健康的口腔与自信的生活。
2006年，Envista盈纬达正式于上海设立总部，并以“植根中国，造福中国，立足中国，服务全球”为发展方向，于江苏苏州与“中国牙谷”四川资阳投资建立两大生产制造基地，不断提升本土研发制造力量，助力中国智造升级。目前 ，Envista盈纬达已搭建完整的本土产业价值链，为中国客户提供及时而完整的全面服务。
Boehringer Ingelheim trabaja en desarrollar terapias innovadoras que mejoren las vidas de humanos y animales. Cerca de 52.000 colaboradores en tres áreas de negocio – Salud Humana, Salud Animal y Fabricación por Contrato de Productos Biofarmacéuticos- y más de 130 mercados, crean valor a través de la innovación en áreas de grandes necesidades médicas insatisfechas como compañía independiente y familiar desde su fundación en 1885.
关于赫力昂
赫力昂（伦敦证交所/ 纽约证交所上市代码：HLN）旨在成为消费健康领域的全球领导者，践行“以人为本，提升每日健康”的公司使命。赫力昂的产品组合涵盖五大品类：口腔健康、疼痛管理、呼吸健康、消化健康、营养健康。赫力昂将深受信赖的科技和对人类健康的理解相结合，打造经典的品牌，包括钙尔奇、善存、舒适达、芬必得、扶他林、新康泰克、百多邦、辅舒良、保丽净等。
如需更多信息，请查阅www.haleon.com
We are a fast-growing, international biotech company committed to our goal of improving the lives of patients through innovative and differentiated
antibody therapeutics.
Eisai’s affiliates in China are wholly-owned by Eisai Co., Ltd. (Eisai), a Japanese multinational pharmaceutical company headquartered in Tokyo, with strong R&D capabilities.
Eisai has been smoothly developing its business in China since the early 1990s, starting with the establishment of Shenyang Eisai Pharmaceutical Co., Ltd. in 1991, followed by the establishment of Eisai Suzhou Pharmaceutical Co., Ltd, and was officially renamed Eisai China.
International Pharma companies
Takeda is a global bio-pharmaceutical company built on traditional values and driven by innovative research. The patient is at the center of everything we do: Takeda is committed to bringing better health and a brighter future to people around the world.